Stock Chart

PODD

$131.69 +0.69%
Score: 51.2 HOLD
LEAPs: SELL $250
i
LEAPs Option Signal

Type: SELL growth_1yr
Strike: $250
Premium: $38.50
Expiry: Dec 18, 2026
Target: $218
Score: -100

LEAPs are long-term options (1+ year) with less time decay.
Pro
Screener
Vol: 1.84x (vs SPY: 1.8x | vs QQQ: 1.8x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Oct 02, 2026
No qualifying chart pattern in the trailing 60 sessions — we only flag setups that pass our quality gate.
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About PODD - Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Key Statistics

Market Cap $9B
P/E Ratio 24.58

This PODD stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track PODD's price movements with trendlines, gamma walls, and key support/resistance levels.